[{"id":"3d7002be-d8b5-4349-98ad-96dccbed9bd4","acronym":"","url":"https://clinicaltrials.gov/study/NCT03687034","created_at":"2021-01-18T18:04:31.389Z","updated_at":"2024-07-02T16:37:02.412Z","phase":"Phase 1","brief_title":"A Study of the Safety and Pharmacokinetics of BRCX014 in Patients With Glioblastoma","source_id_and_acronym":"NCT03687034","lead_sponsor":"Leaf Vertical Inc.","biomarkers":" MGMT","pipe":" | ","alterations":" MGMT promoter methylation","tags":["MGMT"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MGMT promoter methylation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e temozolomide • cannabidiol (BRCX014)"],"overall_status":"Unknown status","enrollment":" Enrollment 21","initiation":"Initiation: 06/01/2019","start_date":" 06/01/2019","primary_txt":" Primary completion: 09/30/2019","primary_completion_date":" 09/30/2019","study_txt":" Completion: 12/31/2020","study_completion_date":" 12/31/2020","last_update_posted":"2019-02-26"}]